Lin Li

The paper identifies cytokine-driven cellular polarization in preeclampsia using single-cell sequencing and machine learning, revealing altered immune cell states and potential therapeutic targets.

This paper develops a selective non-muscle myosin II inhibitor, MT-228, with high brain penetration and efficacy in preclinical models, offering therapeutic potential for diseases like stimulant use disorder.

iAChSnFR, a fluorescent indicator built from a bacterial periplasmic binding protein, reports acetylcholine with large, fast signals in mouse, fish, fly and worm preparations.